The reduced concentration of secondary bile acids results in reduced farnesoid X receptor (FXR) stimulation impacting the repair of the epithelial and GIT vascular barriers and control of metabolic syndrome by increasing glycogen production, decreasing lipogenesis and very low-density lipoprotein production, thereby reducing hepatic glucose and fatty acid output [54,55,56]. This evidence concerns the gene NR1H4 and metabolic syndrome.